Bayesian Capital Management’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,775
Closed -$323K 258
2026
Q1
$323K Buy
+14,775
New +$343K 0.39% 80
2025
Q3
Sell
-16,900
Closed -$372K 638
2025
Q2
$372K Buy
+16,900
New +$369K 0.06% 344
2025
Q1
Sell
-13,400
Closed -$385K 745
2024
Q4
$385K Buy
13,400
+4,200
+46% +$126K 0.05% 431
2024
Q3
$273K Buy
+9,200
New +$286K 0.03% 494
2024
Q2
Sell
-26,700
Closed -$964K 887
2024
Q1
$964K Sell
26,700
-6,000
-18% -$208K 0.09% 289
2023
Q4
$1.07M Buy
+32,700
New +$1.01M 0.11% 221
2022
Q3
Sell
-20,586
Closed -$576K 826
2022
Q2
$576K Buy
20,586
+9,900
+93% +$288K 0.11% 292
2022
Q1
$312K Buy
+10,686
New +$332K 0.05% 509
2021
Q3
Sell
-9,660
Closed -$320K 447
2021
Q2
$320K Buy
+9,660
New +$335K 0.08% 263
2020
Q3
Sell
-12,600
Closed -$325K 584
2020
Q2
$325K Buy
+12,600
New +$316K 0.07% 330
2020
Q1
Sell
-6,946
Closed -$201K 844
2019
Q4
$201K Sell
6,946
-19,500
-74% -$549K 0.03% 533
2019
Q3
$728K Buy
+26,446
New +$699K 0.14% 207
2018
Q2
Sell
-11,325
Closed -$261K 644
2018
Q1
$261K Buy
+11,325
New +$258K 0.07% 431
2016
Q4
Sell
-10,500
Closed -$184K 635
2016
Q3
$184K Buy
+10,500
New +$181K 0.12% 292
2016
Q2
Sell
-11,535
Closed -$181K 452
2016
Q1
$181K Sell
11,535
-700
-6% -$10.2K 0.17% 279
2015
Q4
$196K Buy
+12,235
New +$198K 0.28% 182

Other funds holding GNTX

Bayesian Capital Management's GNTX Position: Q2 2026 in Review

Bayesian Capital Management sold out of Gentex (GNTX) in Q2 2026, closing a stake of 14,775 shares — an estimated $323K sold.

Bayesian Capital Management first reported a position in GNTX in Q4 2015 and held it in 16 quarters. The position peaked at $1.07M in Q4 2023. 528 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Bayesian Capital Management reported no remaining Gentex position as of Q2 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 14,775 Gentex shares in Q2 2026, an estimated $323K.
  • Bayesian Capital Management first reported a position in Gentex in Q4 2015 and held it in 16 quarters.
  • Bayesian Capital Management's Gentex position peaked at $1.07M in Q4 2023.
  • 528 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.